Labshake search
Citations for Tocris :
151 - 200 of 232 citations for Human Rh Blood Group D Antigen RHD CLIA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... Chemicals and drugs were obtained from TOCRIS (d-APV, ALX-5407) and Merck| Sigma-Aldrich (ALX-5407 ...
-
bioRxiv - Neuroscience 2023Quote: ... The recording ACSF was supplemented with D-AP5 (50 µM, Tocris), CNQX (15 µM ...
-
bioRxiv - Cell Biology 2021Quote: Cells were treated with the actin inhibitor Cytochalasin-D (5 μM, Tocris), the Ezrin Inhibitor NSC668394 (50 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5, Tocris Bioscience) were added to the bath to block glutamatergic currents ...
-
bioRxiv - Immunology 2021Quote: ... and 2 ng/ml IL-2 (carrier-free; Tocris R&D Systems). Cells treated with only these functioned as the mock control ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Neuroscience 2022Quote: Experiments were performed in standard aCSF modified with 50μM D-AP5 (Tocris) to block NMDA receptor-mediated currents ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [d-Ala2,MePhe4,Gly (ol)5]enkephalin (DAMGO) was purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2024Quote: For the AMPAR desensitization blocker experiments 50 μM D-APV (Tocris, #0106) and 200 μM CX546 (Tocris ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were treated with 1µM of recombinant human A83-01 (TOCRIS), or 20ng/ml recombinant TGF-β (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... at which point 50nM CRF (human/rat, Cat. No 1151, Tocris) was added to the bath ...
-
bioRxiv - Microbiology 2019Quote: ... Z-VAD-fmk (50 μM; R&D) or MCC950 (5 μM; Tocris Bioscience), were added to cells 1 hour prior to infection ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 μM D,L-2-amino-5-phosphonovaleric acid / AP5 (Tocris Bioscience). Coverslips were mounted in an RC-21BRFS chamber (Warner Instruments ...
-
bioRxiv - Neuroscience 2019Quote: ... 50 µM D-AP5 and 100 µM picrotoxin (all from Tocris Bioscience, UK) which blocked AMPA ...
-
bioRxiv - Neuroscience 2020Quote: Antagonists were bath applied at the following concentrations: D-APV (Tocris Bioscience, 50μM), NBQX (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... currents were pharmacologically isolated by bath application of 50 µM D-APV (Tocris) and 50 µM CNQX (Sigma) ...
-
bioRxiv - Neuroscience 2020Quote: ... and currents were pharmacologically isolated by bath application of 50μM D-APV (Tocris), 10 μM CNQX (Sigma) ...
-
bioRxiv - Microbiology 2021Quote: ... 1 mM orange-red TAMRA-based fluorescent D-amino acid (RADA, Tocris, 6649) was added to the µ-dish ...
-
bioRxiv - Neuroscience 2022Quote: ... Octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10aH-[1,3]dioxocino[6,5-d] pyrimidine-4,7,10,11,12-pentol (Tetrodotoxin: TTX) were purchased from Tocris Bioscience ...
-
bioRxiv - Cell Biology 2021Quote: ... and MRS2179 tetrasodium salt were obtained from Tocris (R&D Systems, Inc, Minneapolis, MN). Isradipine was purchased from Cayman Chemical Company (Ann Arbor ...
-
bioRxiv - Microbiology 2022Quote: ... 1ml of culture was incubated with the fluorescent D-amino acid HADA (Tocris Bioscience) at a final concentration of 250μM for 5 minutes ...
-
bioRxiv - Neuroscience 2023Quote: ... and 50 μM 2-amino-5-phosphonopentanoic acid (D-AP5; Tocris Bioscience, Cambridge, UK) to avoid spontaneous network activation ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105). NH4Cl perfusions were done with 50 mM NH4Cl in substitution of 50 mM NaCl (pH 7.4) ...
-
bioRxiv - Neuroscience 2021Quote: ... then reared in control rearing medium or medium supplemented with 100 µM D-serine (Tocris).
-
bioRxiv - Neuroscience 2022Quote: ... 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate (ARL 67156; Tocris, 1283) was perfused through the probe at concentrations of 1 mM ...
-
bioRxiv - Cell Biology 2022Quote: ... coupled with cutaneous challenge with the Vitamin D analog MC903 (calcipotriol; 2700, Tocris, Bristol, UK) promotes esophageal eosinophilic infiltrates and food impactions (28 ...
-
bioRxiv - Microbiology 2022Quote: NADA (3-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-alanine hydrochloride) was synthesized by Tocris following the published protocol (31) ...
-
bioRxiv - Cell Biology 2021Quote: ... and human vasopressin type 2 receptor (V2R) with [Arg8]-vasopressin (AVP; Tocris 2935, in water). The transfected β-arrestins are of bovine origin ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were maintained in DMEM supplemented with 10% fetal bovine serum and D-APV (500 μM; Tocris) for 48 hrs before experiments.
-
bioRxiv - Pharmacology and Toxicology 2021Quote: Lyophilized and HPLC-purified Human β-Amyloid1-42 (Aβ1-42) peptide was purchased from Tocris (#1428). 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP ...
-
bioRxiv - Cell Biology 2021Quote: ... 20ng/ml human LIF (all from WT-MRC Cambridge Stem Cell Institute) and 2µM Gö6983 (Tocris). For PXGL ...
-
bioRxiv - Neuroscience 2019Quote: ... NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM; Tocris, Cat# 0106) at the end of the recordings ...
-
bioRxiv - Developmental Biology 2020Quote: ... and FGF2 (100 ng/ml, R&D) in the presence or absence of retinoic acid (0.1 µM, Tocris). For paraxial mesoderm differentiation ...
-
bioRxiv - Neuroscience 2021Quote: ... d-2-Amino-5-phosphonovaleric acid (d-AP5, 50µM) and the sodium (Na+) channel blocker tetrodotoxin (TTX, 1 µM Tocris). Individual traces (5 sec duration ...
-
bioRxiv - Neuroscience 2021Quote: ... In a subset of experiments the D1 receptor agonist (SKF81297; 20 mg/kg in saline; Tocris R&D systems), was injected intraperitoneally while recording cADDis photometry signals ...
-
bioRxiv - Cell Biology 2021Quote: ... and 6-O-[(4,5-Dimethoxy-2-nitrophenyl)methyl]-2,3-O-(1-methylethylidene)-D-myo-Inositol 1,4,5-tris[bis[(1-oxopropoxy)methyl]phosphate] (ci-IP3/PM; 1 μM, Tocris #6210) in imaging buffer with 0.01 % BSA in dark at room temperature ...
-
bioRxiv - Developmental Biology 2021Quote: ... Cells were then differentiated for 3 days (D) in N2B27 supplemented with 3 µM Chiron99021 (Tocris, Cat. No. 4953) and 20ng/ml bFGF (PeproTech ...
-
bioRxiv - Neuroscience 2023Quote: ... (5S,10R)-(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine maleate (MK-801, 10 μM dissolved in H2O; Tocris Bioscience), 3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl ...
-
bioRxiv - Cell Biology 2023Quote: ... Cells were incubated in Anteriorization media-1 (100 ng/ml Noggin (R&D/Biotechne) and 10 μM SB431542 (Tocris)) for 24 hours ...
-
bioRxiv - Cell Biology 2024Quote: ... The following inhibitors were resuspended in DMSO and used at the final concentration as indicated: Actinomycin D (1.0 and 2.5 µg/ml; Tocris; 1229); Puromycin (10ug/ml ...
-
bioRxiv - Immunology 2023Quote: ... The scFv library was subjected to four rounds of bio-panning against the human Aβ42 peptide (Tocris Bioscience Amyloid β-Peptide 1-42 human ...
-
bioRxiv - Physiology 2024Quote: Overnight recovered mouse or human islets were cultured with 0.1% DMSO (vehicle) or 9 µM AGK2 (Tocris), 25 µM AK-1 (EMD-Millipore) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human Organoid Growth Medium (HOGM): 50 µl of HOGM consisted of 25 µl A83-01 (1mM, Tocris), 50 µl Human Epidermal Growth Factor (hEGF ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with FGF-2 (20 ng ml−1), Activin-A (50 ng ml−1), BMP-4 (10 ng ml−1, R&D) and LY294002 (10 mM Tocris). Media was changed again after 42 hours to CDM-BSA supplemented with FGF-2 (8 ng ml−1) ...
-
bioRxiv - Neuroscience 2021Quote: ... Drug-evoked locomotor-like activities were induced by bath-applying 10 to 14 µM of N-methyl- D-aspartate (NMDA, Tocris) and serotonin (5-HT ...
-
bioRxiv - Neuroscience 2020Quote: ... Intrinsic properties were recorded in the presence of 10 μM biccuculine methiodide (Enzo, Life Sciences) and 10 μM saclofen (R&D, Tocris). We studied only cells with series resistance < 25 MΩ ...
-
bioRxiv - Developmental Biology 2020Quote: ... day 3 NMP-like cultures were treated with Accutase and replated at a density of 45,000 cells/cm2 on Geltrex-coated plates in N2B27 containing FGF2 (40 ng/ml, R&D) and CHIR99021 (8 µM, Tocris) for two days ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...
-
bioRxiv - Cell Biology 2021Quote: ... The growth medium was supplemented with 100 ng/mL human recombinant epidermal growth factor (EGF) (R&D) as the major growth-supporting peptide and was further supplemented with 10 µM Y27632 (Tocris), 500 nM A83-01 (Tocris) ...
-
bioRxiv - Microbiology 2022Quote: ... 3 μl of 10 mM of NBD-(linezolid-7-nitrobenz-2-oxa-1,3-diazol-4-yl)-amino-D-alanine (NADA) (Tocris Bioscience) was added to the resuspension ...